Long Term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Long Term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain

This study is currently recruiting participants.
Information provided by Insys Therapeutics Inc

Please refer to this study by its ClinicalTrials.gov identifier: NCT00538863

Contacts


Contact: Lauryann Aldon	800 365-9610 ext 333	laldon@clinimetrics.com

Locations


United States, California
	Multiple sites	Recruiting
	United States, California, United States, 00000

Sponsors and Collaborators

Insys Therapeutics Inc

Investigators


Study Director:	Ellen G. Feigal, MD	Chief Medical Officer, Insys Therapeutics Inc